Breast Cancer Drug List in China: Common Endocrine, Targeted, ADC, and Chemotherapy Drugs
The breast cancer drug list in China mainly includes endocrine therapy drugs, HER2-targeted drugs, CDK4/6…
Articles
How to Identify the Early Signs of Melanoma: The ABCDE Rule and Warning Signs
Key Takeaways Melanoma is a malignant tumor that originates from melanocytes and most commonly develops…
What Are the Most Common Chemotherapy Drugs? 10 Frequently Used Medications
What are the most common chemotherapy drugs? Common chemotherapy drugs include Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel,…
Recibokibart Approved for GPP: China-Developed IL-36R Antibody Brings a New Treatment Option for Generalized Pustular Psoriasis
Recibokibart approved for GPP marks a major milestone in Generalized Pustular Psoriasis (GPP) treatment. Developed…
Common Drugs for Prostate Cancer: A Complete Guide to Hormone Therapy, Targeted Therapy & Chemotherapy
Common drugs for prostate cancer include androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs),…
Plozasiran Now Available in China: A Once-Every-3-Month siRNA Therapy for Familial Chylomicronemia Syndrome (FCS)
Plozasiran now available in China marks a milestone for FCS patients, offering a new APOC3-targeted…
Ciprocopan Approved in China as the World’s First Once-Daily Oral CFB Inhibitor for PNH
Ciprocopan approved in China as the world’s first once-daily oral Complement Factor B (CFB) inhibitor,…
Oveporexton Approved First in China: The First OX2R Agonist Targeting the Underlying Mechanism of Type 1 Narcolepsy
Oveporexton approved first in China, becoming the world’s first approved selective orexin receptor 2 (OX2R)…
Gene Therapy for Beta Thalassemia: Can CRISPR and Gene Addition Achieve Transfusion Independence?
For patients living with transfusion-dependent beta thalassemia (TDT), lifelong blood transfusions have long been the…
The First Approved ADC for Esophageal Squamous Cell Carcinoma (ESCC): How Izalontamab Brengitecan Is Transforming Treatment
Izalontamab Brengitecan is the first approved ADC for esophageal squamous cell carcinoma (ESCC) worldwide. It…